$39.99
Research Studies:
FREE Shipping on
orders over $200
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
Sermorelin 5mg is a research-use-only laboratory material supplied for controlled research workflows, compound characterization, and analytical documentation review. It is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.
Sermorelin 5mg is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.
| CAS No. | 86168-78-7 |
|---|---|
| Purity | ≥99% |
| Sequence | Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 |
| Molecular Formula | C149H246N44O42S |
| Molecular Weight | 3357.88 g/mol |
| Synthesis | Solid-phase synthesis |
| Format | Lyophilized powder |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for up to 24 months at -20°C. After reconstitution, may be stored at 4°C for up to 4 weeks or at -20°C for up to 6 months. |
| Applications | Growth hormone release studies, aging research, body composition improvement |
| Appearance | White lyophilized powder |
| Shipping Conditions | Shipped at ambient temperature; once received, store at -20°C |
| Regulatory/Compliance | Manufactured in a facility that adheres to cGMP guidelines |
| Safety Information | Refer to provided MSDS |
Consider these supplementary peptides for a comprehensive research approach.
Researchers searching for buy Sermorelin online should evaluate Sermorelin as a research-use-only laboratory material, not a consumer product. For laboratory buyers, the key considerations are compound identity, Sermorelin purity documentation, batch-specific COA review, lot traceability, product labeling, and supplier evaluation. This guide explains how qualified research teams can evaluate Sermorelin research material for controlled procurement through Pure Lab Peptides while keeping the inquiry limited to research-use-only documentation.
Researchers can buy Sermorelin online for laboratory research by reviewing RUO labeling, batch-specific COA documentation, purity data, identity information, storage guidance, and supplier transparency before selecting a source. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption.
The phrase `buy Sermorelin online` is addressed here as laboratory research procurement intent, not personal-use intent. In a compliant research context, the search is about whether a supplier presents the compound as an RUO material, provides documentation for identity and purity, and supports lot-level recordkeeping. FDA RUO guidance for IVD products distinguishes research labeling from diagnostic positioning, and eCFR labeling language states “For Research Use Only. Not for use in diagnostic procedures” for certain laboratory research-phase products [1] [2].
For technical procurement teams, labeling, purity data, analytical testing, storage information, and lot traceability should be reviewed together. FDA labeling materials for laboratory products emphasize identity, purity or quality statements, storage instructions, and lot or control numbers for relevant reagent categories [3].
Sermorelin is identified by NCBI MeSH as the biologically active fragment of human growth hormone-releasing factor, consisting of GHRH(1-29)-amide [4]. PubChem lists Sermorelin as C149H246N44O42S, while ChEMBL and FDA substance-registration resources identify related Sermorelin acetate records used for compound identity tracking [5] [6] [7]. The IUPHAR/BPS Guide to Pharmacology classifies sermorelin as a peptide ligand and links it to pharmacology database identifiers [8].
In research literature, Sermorelin is discussed in relation to GHRH pathway models and receptor characterization. NCBI Gene describes GHRHR as the growth hormone releasing hormone receptor gene, and UniProt identifies the human GHRHR protein as a receptor coupled to G proteins that activate adenylyl cyclase [9] [10]. This pathway context helps classify the compound for scientific review, but it is not product-use guidance. Pathway relevance in published literature does not establish product-use guidance for RUO materials.
Researchers search this phrase to compare RUO product availability, Sermorelin COA access, product-page labeling, supplier documentation, product form, and batch-specific documentation. A laboratory buyer who intends to buy Sermorelin should confirm that the listing avoids dosing, therapeutic, diagnostic, personal-use, and animal-use positioning. The procurement decision should be based on identity evidence, analytical support for purity, documentation consistency, and transparent storage and handling information.
Procurement review also includes checking lyophilized powder form, analytical support for stated purity, and lot-number consistency. Researchers evaluating Sermorelin supplier documentation should retain records showing product name, lot number, test method, and storage instructions.
Researchers who buy Sermorelin online for laboratory research should evaluate documentation before price or availability. Quality signals are strongest when the product page, label, and COA describe the same compound and lot. HPLC may support purity assessment, while mass-based methods may support identity review.
| Evaluation Area | What Researchers Should Review | Why It Matters for RUO Procurement |
| RUO labeling | Confirm the product is clearly labeled for research use only | Helps separate research procurement from human-use positioning |
| COA availability | Review the batch-specific certificate of analysis | Supports lot-level documentation and quality review |
| Purity data | Look for analytical support for the stated purity | Helps evaluate material consistency |
| Identity testing | Review HPLC, LC-MS, mass spectrometry, or related identity data documented for the batch | Helps confirm the material matches the listed compound |
| Lot traceability | Match lot numbers across product and documentation | Supports research recordkeeping |
| Product form | Confirm whether the material is supplied as lyophilized powder or another documented form | Supports laboratory planning |
| Storage information | Review storage and handling documentation | Helps maintain material integrity in laboratory settings |
| Supplier language | Confirm the supplier avoids dosing, therapeutic, diagnostic, or personal-use claims | Supports research-use-only positioning |
The Sermorelin COA should be reviewed as a batch-specific record, not a general marketing statement. Researchers should look for compound name, lot number, test date, purity percentage, testing method, identity confirmation, molecular weight or sequence when documented, chromatogram or mass data, product form, and storage documentation. FDA analytical-method guidance describes validation data as support for identity, strength, quality, purity, and potency documentation in regulated drug and biologic contexts [11].
A purity percentage alone does not establish complete compound identity; researchers should evaluate purity, identity, method, lot number, and documentation together. FDA Q2(R2) guidance addresses analytical validation for identity, purity, impurity, and qualitative or quantitative measurements, while USP chromatography resources describe general chromatography and system suitability concepts [12] [13]. The eCFR also illustrates why identity verification and supplier-analysis reliability matter in regulated component control [14].
Published literature has examined Sermorelin and GHRH(1-29)-amide in database, analytical, receptor, and clinical-history contexts. A review by Prakash and Goa describes Sermorelin as a 29-amino-acid analogue of human GHRH, while earlier studies compared GHRH(1-29)-amide and related analogues in controlled research settings [15] [16] [17]. Published clinical literature should not be interpreted as use guidance for RUO materials.
Other literature discusses GHRH analogue chemistry, peptide modification, and receptor biology. Esposito and colleagues reviewed PEGylation of GRF analogues, while Gaylinn, Lin-Su, and Wajnrajch reviewed GHRH receptor biology and signaling context [18] [19] [20] [21]. Structural work has also examined the human GHRH receptor, including cryo-EM analysis of receptor activation, and recent reviews summarize GHRH receptor variants in research models [22] [23]. These publications provide scientific context for compound classification and pathway terminology, not instructions for use.
| Research Area | What Literature Examines | Evidence Type | RUO Interpretation |
| Compound identity | Molecular structure, sequence, formula, classification, and database identifiers | Database / analytical | Supports identification, not product-use claims |
| Pathway or category context | GHRH receptor, peptide ligand class, and receptor-signaling research | Review / in vitro / structural / clinical-history literature | Useful for research context, not therapeutic claims |
| Analytical testing | Purity, identity, method validation, chromatography, and batch verification | HPLC / LC-MS / mass spectrometry / COA | Supports documentation review |
| Storage and stability | Material form, label instructions, and handling documentation | Laboratory documentation | Supports research workflow planning |
The evidence landscape should be read conservatively. Database records and peer-reviewed articles can explain compound identity and pathway terminology, but they do not validate a specific RUO batch or create product-use instructions.
| Research-Safe Statement | Why It Is Acceptable | Non-Compliant Version to Avoid |
| “Sermorelin is discussed in published research related to GHRH receptor and peptide ligand models.” | Describes literature context without making a product claim | “Sermorelin helps with a human outcome.” |
| “Researchers should review COA and identity data before procurement.” | Focuses on documentation and quality review | “Users should buy Sermorelin for results.” |
| “Pure Lab Peptides supplies Sermorelin as a research-use-only material.” | Clarifies intended use | “Pure Lab Peptides supplies Sermorelin for therapy.” |
| “The phrase buy Sermorelin online is addressed as research procurement intent.” | Qualifies commercial search intent | “Buy Sermorelin online for personal use.” |
| “Pathway relevance in published literature does not establish product-use guidance for RUO materials.” | Separates research context from use instructions | “GHRH pathway context means the product should be used for a desired outcome.” |
Pure Lab Peptides presents Sermorelin 5mg as a research-use-only material for qualified laboratory procurement. The product is supplied as lyophilized powder, carries a ≥99% purity claim, and has a batch-specific COA available for review. Researchers should review the product page and batch-specific documentation for RUO labeling, purity information, identity documentation, storage guidance, and lot-level traceability.
Review the Pure Lab Peptides Sermorelin research-use-only product details page for RUO labeling, product details, purity information, and batch-specific documentation. For supplier context, review the research peptide collection, educational blog archive, and shipping and returns information.
Buy Sermorelin online should not be interpreted as personal-use guidance on this page. The phrase is addressed as laboratory procurement intent for qualified researchers reviewing RUO labeling, documentation, purity data, identity information, and supplier transparency.
Published research may discuss GHRH(1-29)-amide, receptor models, or clinical-history literature, but those papers do not provide RUO material instructions. Research context should not be converted into product claims.
Sermorelin purity documentation is important, but a purity value alone is not the same as full identity review. Researchers should evaluate the COA, method, lot number, molecular identity, and chromatographic or mass-based evidence together.
A general sample report is weaker than batch-specific documentation. For RUO procurement, the COA should match the exact lot received, and the product name, lot number, product form, and stated purity should align across records.
Supplier language should not replace Sermorelin identity testing or documentation review. Procurement teams should prioritize batch-specific COAs, analytical methods, transparent labeling, and lot-level traceability.
Researchers can review Sermorelin online through RUO suppliers that provide clear labeling, batch-specific COA documentation, purity information, identity data, product form, and storage guidance. Pure Lab Peptides lists Sermorelin 5mg as a research-use-only lyophilized powder with batch-specific COA availability.
Before buying Sermorelin online, researchers should check RUO labeling, the batch-specific COA, product name consistency, lot number matching, purity documentation, identity testing, storage information, and supplier language. The supplier should not position the material for personal, clinical, diagnostic, or animal use.
A COA matters when buying Sermorelin because it provides batch-specific documentation for quality review. Researchers should examine the compound name, lot number, test date, purity value, analytical method, identity evidence, and product-form information together rather than relying on one data point.
Sermorelin discussed here is not intended for human or animal consumption. This article addresses research procurement only. Qualified laboratories should evaluate RUO labeling, product documentation, and supplier transparency while avoiding any interpretation related to personal use, clinical use, or veterinary use.
Research use only means Sermorelin is presented as a laboratory research material for controlled research settings. RUO positioning requires careful separation from diagnostic, therapeutic, personal-use, and animal-use claims. Procurement review should focus on documentation, identity, purity, traceability, and storage records.
Published literature about Sermorelin should be interpreted as scientific context, not product-use guidance. Papers may discuss compound identity, peptide classification, GHRH receptor research, analytical methods, or historical clinical literature. Those findings do not validate a specific RUO batch or create use instructions.
Qualified researchers evaluating Sermorelin should review product labeling, COA status, identity documentation, storage information, and supplier transparency before selecting any research-use-only material. Review the Sermorelin product page for RUO labeling, purity information, and available batch-specific documentation.
Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.
Discount Applied Successfully!
Your savings have been added to the cart.
There are no reviews yet.